Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D G Page

Showing results (61-70 of 74) with videos related to

Pageof 8
Sort By:
Journal of Medicinal Chemistry|August 24, 2013
Inhibiting aberrant signal transducer and activator of transcription protein activation with tetrapodal, small molecule Src homology 2 domain binders: promising agents against multiple myelomaBrent D G Page, Danielle C Croucher, Zhi Hua Li, et al.
The Journal of Biological Chemistry|December 26, 2021
The antimicrobial drug pyrimethamine inhibits STAT3 transcriptional activity by targeting the enzyme dihydrofolate reductaseLisa N Heppler, Sanaz Attarha, Rosanne Persaud, et al.
Metabolites|February 25, 2023
Cycloguanil and Analogues Potently Target DHFR in Cancer Cells to Elicit Anti-Cancer ActivityJennifer I Brown, Peng Wang, Alan Y L Wong, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Potent Targeting of the STAT3 Protein in Brain Cancer Stem Cells: A Promising Route for Treating GlioblastomaSina Haftchenary, H Artee Luchman, Andriana O Jouk, et al.
Science Signaling|April 24, 2014
Dynamic reprogramming of signaling upon met inhibition reveals a mechanism of drug resistance in gastric cancerAndrea Z Lai, Sean Cory, Hong Zhao, et al.
Cell Chemical Biology|June 30, 2021
NUDT15-mediated hydrolysis limits the efficacy of anti-HCMV drug ganciclovirSi Min Zhang, Daniel Rehling, Ann-Sofie Jemth, et al.
Nature Communications|December 6, 2024
Coupling cellular drug-target engagement to downstream pharmacology with CeTEAMNicholas C K Valerie, Kumar Sanjiv, Oliver Mortusewicz, et al.
Molecular Cancer Therapeutics|February 14, 2016
Applying Small Molecule Signal Transducer and Activator of Transcription-3 (STAT3) Protein Inhibitors as Pancreatic Cancer TherapeuticsCarolyn C Arpin, Stephen Mac, Yanlin Jiang, et al.
Nature Communications|January 19, 2018
Targeted NUDT5 inhibitors block hormone signaling in breast cancer cellsBrent D G Page, Nicholas C K Valerie, Roni H G Wright, et al.
Nature Communications|November 3, 2019
Author Correction: Targeted NUDT5 inhibitors block hormone signaling in breast cancer cellsBrent D G Page, Nicholas C K Valerie, Roni H G Wright, et al.
Pageof 8

Showing results (61-70 of 74) with videos related to

Sort By:
Pageof 8
Journal of Medicinal Chemistry|August 24, 2013
Inhibiting aberrant signal transducer and activator of transcription protein activation with tetrapodal, small molecule Src homology 2 domain binders: promising agents against multiple myelomaBrent D G Page, Danielle C Croucher, Zhi Hua Li, et al.
The Journal of Biological Chemistry|December 26, 2021
The antimicrobial drug pyrimethamine inhibits STAT3 transcriptional activity by targeting the enzyme dihydrofolate reductaseLisa N Heppler, Sanaz Attarha, Rosanne Persaud, et al.
Metabolites|February 25, 2023
Cycloguanil and Analogues Potently Target DHFR in Cancer Cells to Elicit Anti-Cancer ActivityJennifer I Brown, Peng Wang, Alan Y L Wong, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Potent Targeting of the STAT3 Protein in Brain Cancer Stem Cells: A Promising Route for Treating GlioblastomaSina Haftchenary, H Artee Luchman, Andriana O Jouk, et al.
Science Signaling|April 24, 2014
Dynamic reprogramming of signaling upon met inhibition reveals a mechanism of drug resistance in gastric cancerAndrea Z Lai, Sean Cory, Hong Zhao, et al.
Cell Chemical Biology|June 30, 2021
NUDT15-mediated hydrolysis limits the efficacy of anti-HCMV drug ganciclovirSi Min Zhang, Daniel Rehling, Ann-Sofie Jemth, et al.
Nature Communications|December 6, 2024
Coupling cellular drug-target engagement to downstream pharmacology with CeTEAMNicholas C K Valerie, Kumar Sanjiv, Oliver Mortusewicz, et al.
Molecular Cancer Therapeutics|February 14, 2016
Applying Small Molecule Signal Transducer and Activator of Transcription-3 (STAT3) Protein Inhibitors as Pancreatic Cancer TherapeuticsCarolyn C Arpin, Stephen Mac, Yanlin Jiang, et al.
Nature Communications|January 19, 2018
Targeted NUDT5 inhibitors block hormone signaling in breast cancer cellsBrent D G Page, Nicholas C K Valerie, Roni H G Wright, et al.
Nature Communications|November 3, 2019
Author Correction: Targeted NUDT5 inhibitors block hormone signaling in breast cancer cellsBrent D G Page, Nicholas C K Valerie, Roni H G Wright, et al.
Pageof 8